IMU = 2.2B
CSL = 132B
I’m starting this thread(which I will update from time to time) because I believe Imugene will surpass the CSL market cap within ten years, assuming we are not taken over before then.
I’ve watched and been in and out of Imugene for three years. Imugene is an IP junkie. They are hungry to take over programs and collect IP at the forefront of I/O and they vigorously pursue their IP through the clinic and the early results are proving phenomenal.
Imugene is becoming a centre of gravity in the I/O space which will suck more prestige talent and programs towards it, and more investment.
This flywheel effect, combined with great results and huge mkt potential, will see IMU become a global colossus in the I/O arena.I honestly believe we will run down CSL within ten years.
And it will be one hell of a ride if we do!
See you down the road!
(20min delay)